Fabrication of Neodymium (Nd), Cadmium (Cd) and Nd:Cd doped hybrid copper oxide nanocomposites: Evaluation of their antibacterial activity and cytotoxicity against human L132 cell line

In the present study, Neodymium (Nd), Cadmium (Cd), and the various molar ratios of Nd: Cd doped copper oxide nanocomposites (CuO NCs) were prepared by the co-precipitation method. The as-synthesized Nd, Cd, and Nd:Cd doped CuO NCs [Cu1-x + yNdxCdyO, (x:y = 0.006:0.00, 0.00:0.006, 0.005:0.001, 0.004:0.002, 0.003:0.003, M)] were characterized through various instrumentation techniques such as TGA, UV-Vis-NIR, FTIR, Raman, FL, XRD, ZP, FE-SEM with EDAX elemental mapping, HR-TEM and XPS analyses. Further, the antibacterial activity of doped CuO NCs was tested against Staphylococcus aureus and Escherichia coli. An equal molar ratio of Nd and Cd doped CuO NCs showed excellent antibacterial activity mainly due to the synergistic effect of sufficient Nd3+, Cd2+, and Cu2+ ions releasing ability. Interestingly, the doping effect enhances surface defects and decreases the ability to scavenge free radicals compared to pure CuO nanomaterials. At the same time, the cytotoxicity of NCs was evaluated on the human lung epithelial L132 cell line. Evidently, 75 mu g/ml concentration of Nd:Cd doped CuO NCs samples shows 80% viability, which confirms their negligible cytotoxic effect. The Nd:Cd doped CuO NCs (94:3:3) had a high aspect ratio shape, remarkable ion-releasing ability, and biocompatibility while being thermally stable. Because of these qualities, they are well suited for treating bacterial infections in the biomedical area.